the market?
Arena Pharmaceuticals, Inc.
NASDAQ: ARNA
7.51
0.01
(0.13%)
| Today's Open | $7.51 |
|---|---|
| Previous Close | $7.50 |
| Daily Range | $7.40 - $7.57 |
| 52-Week Range | $6.95 - $13.50 |
| Market Cap | $1.6B |
| P/E Ratio | -20.83 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 5,376,715 |
| Average Daily Volume | 5,805,840 |
| Current FY EPS | -$0.12 |
How do you think ARNA
will perform against the market?
Top ARNA Bull/Bear Pitches
weightlossman (0)
Submitted
August 31, 2010
Arena Pharma's (ARNA) Lorcaserin will eventually be approved. It's side effects are benign. Research has shown that it does not cause pulmonary hypertension nor heart-valve damage. Arena has comple … More
DarthMaul09 (< 20)
Submitted
July 23, 2010
Even if a new med is found to be clinically useful and has made it past the FDA, then it needs to get past insurance companies and be marketed adequately to physicians, who still remember Fen/Fen and … More
News & Commentary
The Top 5 Diseases Caused by Obesity
Obesity accounts for 21% of all health-care expenditures annually, and it's a leading risk factor for these five diseases.Pre-Market Most Active for Jun 12, 2013 : CTB, NCT, WDAY, BAC, VOD, S, NOK, GT, GRFS, ARNA, SIRI, C
Pre-Market Most Active for Jun 12, 2013 : CTB, NCT, WDAY, BAC, VOD, S, NOK, GT, GRFS, ARNA, SIRI, CLVSThe Obesity-Drug Wars Officially Begin
With Arena's Belviq is finally commercially available, the obesity drug wars can start.The 3 Biggest Risk Factors for a Stroke
Stroke is the fourth-leading cause of death in the U.S. Today, we'll look at the biggest risk factors of this disease, as well as things you can do to reduce your risk of having a stroke.New Obesity Drug Hits the Market
There's plenty of room for two drugs in an expanding market. Here's what investors need to know.Stocks to Buy: Biotechs With Growth Potential
They're still risky though.Sector
Healthcare
Industry
Drugs
Arena Pharmaceuticals, Inc. (ARNA) Description
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/
CEO Rating by Glassdoor
More details for Arena Pharmaceuticals Jobs
Arena Pharmaceuticals reviews from employees
